levofloxacin has been researched along with spectinomycin in 9 studies
| Studies (levofloxacin) | Trials (levofloxacin) | Recent Studies (post-2010) (levofloxacin) | Studies (spectinomycin) | Trials (spectinomycin) | Recent Studies (post-2010) (spectinomycin) |
|---|---|---|---|---|---|
| 4,346 | 581 | 2,209 | 1,312 | 87 | 191 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 5 (55.56) | 29.6817 |
| 2010's | 4 (44.44) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chan, YY; Chua, KL; Ong, YM | 1 |
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Choi, SS; Contrera, JF; Hastings, KL; Kruhlak, NL; Sancilio, LF; Weaver, JL; Willard, JM | 1 |
| Glen, RC; Lowe, R; Mitchell, JB | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Ashenden, S; Bender, A; Cokol, M; Karakoc, I; Kuru, N; Mason, DJ; Meral, S; Stott, I; Weinstein, ZB | 1 |
| Abe, H; Aoto, T; Nishimura, T; Norose, Y; Ohkuni, H; Ohzuka, H | 1 |
| Fujimoto, Y; Komeda, H; Takada, T; Uno, M; Yamada, Y | 1 |
| Ahmed, F; Barrow, R; Bornstein, M; Risley, JF; Simmons, S; Workowski, KA | 1 |
1 review(s) available for levofloxacin and spectinomycin
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
8 other study(ies) available for levofloxacin and spectinomycin
| Article | Year |
|---|---|
Synergistic interaction between phenothiazines and antimicrobial agents against Burkholderia pseudomallei.
Topics: Anti-Infective Agents; Burkholderia pseudomallei; Cells, Cultured; Drug Synergism; Humans; Lung; Macrophages; Melioidosis; Microbial Sensitivity Tests; Phenothiazines; Proton Pump Inhibitors | 2007 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Development of a phospholipidosis database and predictive quantitative structure-activity relationship (QSAR) models.
Topics: | 2008 |
Predicting phospholipidosis using machine learning.
Topics: Animals; Artificial Intelligence; Databases, Factual; Drug Discovery; Humans; Lipidoses; Models, Biological; Phospholipids; Support Vector Machine | 2010 |
Prediction of Antibiotic Interactions Using Descriptors Derived from Molecular Structure.
Topics: Anti-Bacterial Agents; Drug Interactions; Molecular Structure | 2017 |
Frequency of alterations in the GyrA subunit of DNA gyrase and the ParC subunit of topoisomerase IV in 19 clinical isolates of Neisseria gonorrhoeae in Tokyo in 2002.
Topics: Anti-Bacterial Agents; DNA Gyrase; DNA Topoisomerase IV; Drug Resistance, Bacterial; Gonorrhea; Humans; Levofloxacin; Male; Microbial Sensitivity Tests; Mutation; Neisseria gonorrhoeae; Ofloxacin; Prevalence; Spectinomycin; Tokyo; Urethritis | 2003 |
[Clinical study of male urethritis in Oogaki Municipal Hospital].
Topics: Adolescent; Adult; Anti-Bacterial Agents; Chlamydia Infections; Fluoroquinolones; Gonorrhea; Hospitals, Municipal; Humans; Japan; Levofloxacin; Male; Middle Aged; Minocycline; Naphthyridines; Ofloxacin; Sexual Partners; Sexually Transmitted Diseases, Bacterial; Spectinomycin; Urethritis | 2005 |
Factors Associated With Primary Care Physician Knowledge of the Recommended Regimen for Treating Gonorrhea.
Topics: Adult; Anti-Bacterial Agents; Azithromycin; Ceftriaxone; Chi-Square Distribution; Clinical Protocols; Drug Therapy, Combination; Female; Gonorrhea; Health Knowledge, Attitudes, Practice; Humans; Levofloxacin; Logistic Models; Male; Middle Aged; Physicians, Primary Care; Practice Patterns, Physicians'; Primary Health Care; Spectinomycin | 2017 |